[Blood vessel multiply and significance of expression of Cox-2, VEGF in pterygium].
To investigate the role of cyclooxygenases-2 (Cox-2) and vascular endothelial growth factor (VEGF) in the occurrence and development of human pterygium. The immunohistochemical elivision method was used to examine the expressions of Cox-2 and VEGF in 30 cases of pterygium and 15 cases with normal conjunctiva. The positive rate of Cox-2 was 42.8% in resting stage, 84.6% in active stage, 90.0% in recurrent pterygium and 6.6% in normal conjunctiva. The positive rate of VEGF was 57.1% in resting stage, 69.2% in active stage, 100.0% in recurrent pterygium and 13.3% in the normal conjunctiva. There was significant difference in the expressions of Cox-2 and VEGF between the pterygium and normal conjunctiva (P < 0.05, P < 0.001). There are high Cox-2 and VEGF expressions in pterygium, which suggests that there is abnormal blood vessel multiply in pterygium, and the Cox-2 and VEGF plays an important role in the incidence and development of pterygium. Specific Cox-2 and VEGF inhibitor become a new target for the therapy of pterygium. Specific Cox-2 and VEGF inhibitor become a new target for the therapy of pterygium.